Company
United StatesSingaravelu Jagadeesan, Raleigh, NC – FDA Inspections
Inspection records and compliance data for Singaravelu Jagadeesan in Raleigh, North Carolina. 2 FDA inspections on record, last inspected May 20, 2022.
Company Profile
This profile covers Singaravelu Jagadeesan based in Raleigh, North Carolina, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected February 26, 2018. Last inspected May 20, 2022.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 20, 2022 | NAI | Human Drugs · Bioresearch Monitoring | 1170495 |
| February 26, 2018 | NAI | Human Drugs · Bioresearch Monitoring | 1043296 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Singaravelu Jagadeesan
FEI Number
3014126616
Address
M3 Wake Research/Carolina Phase I Research, 3100 Duraleigh Rd Ste 304, Raleigh, North Carolina 27612, United States
Country
United States
ID: dc7c8fdd-b06a-486a-a937-1b96eed0d255